 | Up a level |
Journal Article
Giugliano, Robert P., Pedersen, Terje R., Park, Jeong-Gun, De Ferrari, Gaetano M., Gaciong, Zbigniew A., Ceska, Richard, Toth, Kalman, Gouni-Berthold, Ioanna, Lopez-Miranda, Jose 
ORCID: 0000-0002-8844-0718, Schiele, Francois, Mach, Francois, Ott, Brian R., Kanevsky, Estelle, Pineda, Armando Lira, Somaratne, Ransi, Wasserman, Scott M., Keech, Anthony C., Sever, Peter S. and Sabatine, Marc S.
(2017).
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.
Lancet, 390 (10106).
S. 1962 - 1972.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Nissen, Steven E., Stroes, Erik, Dent-Acosta, Ricardo E., Rosenson, Robert S., Lehman, Sam J., Sattar, Naveed, Preiss, David ORCID: 0000-0003-3139-1836, Bruckert, Eric, Ceska, Richard ORCID: 0000-0002-2541-5179, Lepor, Norman, Ballantyne, Christie M., Gouni-Berthold, Ioanna, Elliott, Mary, Brennan, Danielle M., Wasserman, Scott M., Somaratne, Ransi, Scott, Rob and Stein, Evan A.
(2016).
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance The GAUSS-3 Randomized Clinical Trial.
JAMA-J. Am. Med. Assoc., 315 (15).
S. 1580 - 1591.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 1538-3598
Raal, Frederick J., Stein, Evan A., Dufour, Robert, Turner, Traci, Civeira, Fernando, Burgess, Lesley, Langslet, Gisle, Scott, Russell ORCID: 0000-0002-2107-6480, Olsson, Anders G., Sullivan, David, Hovingh, G. Kees, Cariou, Bertrand ORCID: 0000-0002-1580-8040, Gouni-Berthold, Ioanna, Somaratne, Ransi, Bridges, Ian, Scott, Rob, Wasserman, Scott M. and Gaudet, Daniel
(2015).
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.
Lancet, 385 (9965).
S. 331 - 341.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X